全文获取类型
收费全文 | 930篇 |
免费 | 38篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 55篇 |
妇产科学 | 15篇 |
基础医学 | 152篇 |
口腔科学 | 14篇 |
临床医学 | 77篇 |
内科学 | 212篇 |
皮肤病学 | 13篇 |
神经病学 | 51篇 |
特种医学 | 154篇 |
外科学 | 67篇 |
综合类 | 11篇 |
预防医学 | 39篇 |
眼科学 | 4篇 |
药学 | 60篇 |
1篇 | |
中国医学 | 6篇 |
肿瘤学 | 39篇 |
出版年
2023年 | 4篇 |
2022年 | 7篇 |
2021年 | 15篇 |
2020年 | 7篇 |
2019年 | 7篇 |
2018年 | 15篇 |
2017年 | 15篇 |
2016年 | 12篇 |
2015年 | 12篇 |
2014年 | 15篇 |
2013年 | 26篇 |
2012年 | 27篇 |
2011年 | 31篇 |
2010年 | 35篇 |
2009年 | 34篇 |
2008年 | 29篇 |
2007年 | 43篇 |
2006年 | 32篇 |
2005年 | 22篇 |
2004年 | 20篇 |
2003年 | 26篇 |
2002年 | 22篇 |
2001年 | 34篇 |
2000年 | 21篇 |
1999年 | 17篇 |
1998年 | 30篇 |
1997年 | 31篇 |
1996年 | 43篇 |
1995年 | 40篇 |
1994年 | 36篇 |
1993年 | 23篇 |
1992年 | 15篇 |
1991年 | 16篇 |
1990年 | 17篇 |
1989年 | 25篇 |
1988年 | 29篇 |
1987年 | 17篇 |
1986年 | 14篇 |
1985年 | 19篇 |
1984年 | 13篇 |
1983年 | 9篇 |
1982年 | 9篇 |
1981年 | 10篇 |
1980年 | 12篇 |
1978年 | 4篇 |
1977年 | 7篇 |
1976年 | 6篇 |
1975年 | 5篇 |
1971年 | 3篇 |
1969年 | 3篇 |
排序方式: 共有977条查询结果,搜索用时 15 毫秒
71.
Dingding Lin Maury A. Nussbaum Hyang Seol Navrag B. Singh Michael L. Madigan Laura A. Wojcik 《European journal of applied physiology》2009,106(3):425-434
The purposes of this study were to investigate the effects of fatigue location and age on changes in postural control induced
by localized muscle fatigue, as well as the patterns of recovery post-fatigue. Groups of 16 younger (18–25 years) and 16 older
(55–65 years) participants performed submaximal isotonic fatiguing exercises involving the unilateral ankle plantar flexors,
knee extensors, and shoulder flexors, and bilateral lumbar extensors. Postural control was assessed during quiet upright stance,
from center-of-pressure and center-of-mass time series obtained before and after the fatiguing exercises. Acute effects of
fatigue differed between joints, with the most substantial effects evident at the lower back, followed by the ankle. Neither
knee nor shoulder fatigue resulted in significant effects on postural control. Significant acute effects of fatigue were found
only among the younger group. Recovery of postural control post-fatigue was influenced by age, being more rapid in the younger
group, but not by fatigue location. Along with existing evidence, these results may facilitate the development of strategies
to prevent occupational falls. 相似文献
72.
Background and purpose:
Angiotensin II receptor antagonists (ARBs), originally developed for antihypertensive properties, have pleiotropic effects including direct vascular actions. We tested the hypothesis that the ARB irbesartan would be effective against micro- and macrovascular complications of the prediabetic metabolic syndrome using the obese, insulin-resistant JCR : LA-cp rat that exhibits micro- and macrovascular disease with ischaemic myocardial lesions and renal disease.Experimental approach:
Obese male rats were treated with irbesartan (30 mg·kg−1·day−1, incorporated into chow) from 12 to 25 weeks of age.Key results:
Irbesartan treatment caused no change in food intake or body weight. Fasting glycaemic control of the JCR : LA-cp rats was marginally improved, at the expense of increased plasma insulin levels (∼50%). Fasting plasma triglycerides were marginally reduced (∼25%), while cholesterol concentrations were unchanged. Elevated concentrations of adiponectin, monocyte chemotactic protein-1 and plasminogen activator inhibitor-1 were reduced along with severity of glomerular sclerosis. Macrovascular dysfunction (aortic hypercontractile response to noradrenergic stimulus and reduced endothelium-dependent relaxation) was improved and frequency of ischaemic myocardial lesions reduced (62%).Conclusions and implications:
Irbesartan reduces markers of inflammation and prothombotic status, improves macrovascular function and reduces glomerular sclerosis and myocardial lesions in a model of the metabolic syndrome. Unlike pharmaceutical agents targeted on metabolic dysfunction, irbesartan reduced end-stage disease without major reduction of plasma lipids or insulin. The protective effects appear to be secondary to unknown intracellular mechanisms, probably involving signal transduction pathways. Understanding these would offer novel pharmaceutical approaches to protection against cardiovascular disease. 相似文献73.
74.
SE Andrew 《Clinical genetics》2003,64(4):293-296
75.
Kirkpatrick SE; Pitlick PT; Naliboff J; Friedman WF 《The American journal of physiology》1976,231(2):495-500
76.
77.
PJ Fielder SE Gargosky M Vaccarello K Wilson P Cohen F Diamond J Guevara-Aguirre AL Rosenbloom RG Rosenfeld 《Acta paediatrica (Oslo, Norway : 1992)》1993,82(S389):40-43
Six adult patients with growth hormone receptor deficiency (GHRD) (2 men, 4 women) with an identical defect in the growth hormone receptor (GHR) gene, were treated with recombinant human insulin-like growth factor I (IGF-I), 40 μgikg S.C. twice daily, for 7 days. Serum concentrations of IGF peptide and IGF binding protein-3 (IGFBP-3) were measured by specific radioimmunoassays; serum IGFBPs were also measured by Western ligand blotting. The size distribution of both IGF-I and IGF-II was measured in serum following size-exclusion fast-performance liquid chromatography. IGF-I treatment resulted in a normalization of serum IGF-I levels on days 1–7 of treatment and a decrease in serum IGF-II levels. The fall in IGF-II levels and the simultaneous rise in IGF-I levels, however, resulted in an unchanged total serum IGF level. The low IGFBP-3 values did not significantly change during treatment, whereas there was a slight increase in IGFBP-2 levels. Preliminary analysis of size-fractionated sera suggested an increase in IGF-I levels in the 40 and 150 kDa regions at the expense of IGF-II levels. The results suggest that despite the failure of IGF-I treatment to increase IGFBPs significantly, serum IGFBP concentrations were sufficient to maintain normal levels of IGF-I. 0 Laron syndrome, growth hormone receptor deficiency, insulin-like growth factors, insulin-like growth factor binding protein 相似文献
78.
Braffman BH; Coleman BG; Ramchandani P; Arger PH; Nodine CF; Dinsmore BJ; Louie A; Betsch SE 《Radiology》1994,190(3):797
79.
Ketai LH; Williamson MR; Telepak RJ; Levy H; Koster FT; Nolte KB; Allen SE 《Radiology》1994,191(3):665
80.
The effects of antioxidant supplementation during Percoll preparation on human sperm DNA integrity 总被引:20,自引:6,他引:20
Hughes CM; Lewis SE; McKelvey-Martin VJ; Thompson W 《Human reproduction (Oxford, England)》1998,13(5):1240-1247
The integrity of sperm DNA is crucial for the maintenance of genetic
health. A major source of damage is reactive oxygen species (ROS)
generation; therefore, antioxidants may afford protection to sperm DNA. The
objectives of the study were, first, to measure the effects of antioxidant
supplementation in vitro on endogenous DNA damage in spermatozoa using the
single cell gel electrophoresis (comet) assay and, second, to assess the
effect of antioxidant supplementation given prior to X-ray irradiation on
induced DNA damage. Spermatozoa from 150 patients were prepared by Percoll
centrifugation in the presence of ascorbic acid (300, 600 microM), alpha
tocopherol (30, 60 microM), urate (200, 400 microM), or acetyl cysteine (5,
10 microM). DNA damage was induced by 30 Gy X-irradiation. DNA strand
breakage was measured using the comet assay. Sperm DNA was protected from
DNA damage by ascorbic acid (600 microM), alpha tocopherol (30 and 60
microM) and urate (400 microM). These antioxidants provided protection from
subsequent DNA damage by X-ray irradiation. In contrast, acetyl cysteine or
ascorbate and alpha tocopherol together induced further DNA damage.
Supplementation in vitro with the antioxidants ascorbate, urate and alpha
tocopherol separately has beneficial effects for sperm DNA integrity.
相似文献